Tripodi M F, Rambaldi A, Utili R, Rosario P, Attanasio V, Locatelli A, Adinolfi L E, Andreana A, Florio A, Ruggiero G
Institute of Medical Therapy, Second University of Naples, Italy.
New Microbiol. 1995 Jul;18(3):319-23.
We conducted a study on 81 clinical isolates of enterococci (65 Enterococcus faecalis and 16 Enterococcus faecium) collected consecutively over a one year period at our University Hospital. Of them, 10 (15%) Enterococcus faecalis and 6 (38%) Enterococcus faecium showed high level resistance to aminoglycosides, were all acquired in surgical units and in five cases they were responsible for invasive infections. Ampicillin and imipenem were active only against Enterococcus faecalis. Vancomycin and teicoplanin were bacteriostatic; however, teicoplanin MICs were lower and in 45% of cases its MBC values were within clinically achievable serum concentrations. Ciprofloxacin and cotrimoxazole were active in vitro.
我们对在我校医院连续一年收集的81株肠球菌临床分离株(65株粪肠球菌和16株屎肠球菌)进行了研究。其中,10株(15%)粪肠球菌和6株(38%)屎肠球菌对氨基糖苷类药物表现出高水平耐药,均在外科病房获得,且在5例病例中它们导致了侵袭性感染。氨苄西林和亚胺培南仅对粪肠球菌有活性。万古霉素和替考拉宁具有抑菌作用;然而,替考拉宁的最低抑菌浓度较低,在45%的病例中其最低杀菌浓度值在临床可达到的血清浓度范围内。环丙沙星和复方新诺明在体外有活性。